ApoC-III and visceral adipose tissue contribute to paradoxically normal triglyceride levels in insulin-resistant African-American women

Table 2 Fasting lipids and apolipoproteins ¹

Variable	African-Americans	Whites	P-Value²
Whole plasma – Chol (mg/dL)	171 (160, 189)	184 (123, 217)	0.968
Whole plasma – TG (mg/dL)	56 (44, 82)	87 (65, 131)	0.038
Whole plasma - HDL-C (mg/dL)	58 (51, 74)	45 (38, 52)	0.014
Whole plasma - LDL-C (mg/dL)	85 (71, 103)	91 (61, 119)	0.527
Whole plasma - ApoB (mg/dL)	47 (35, 57)	62 (47, 72)	0.058
Whole plasma - ApoCIII (mg/dL)	10.06 (6.58, 14.78)	11.06 (8.32, 13.75)	0.843
Whole plasma - ApoE (mg/dL)	9.01 (5.61, 11.2)	5.94 (5.21, 8.70)	0.133
Light VLDL-TG (mg/dL)	15.8 (6.8, 24.1)	35.9 (19.5, 65.7)	0.014
Light VLDL-apoB (mg/dL)	1.52 (0.66, 3.29)	2.76 (1.59, 6.30)	0.063
Light VLDL-apoCIII (mg/dL)	0.87 (0.53, 1.55)	1.50 0.76, 2.71)	0.304
Light VLDL-apoE (mg/dL)	0.63 (0.35, 1.43)	0.38 (0.30, 0.82)	0.192
Dense VLDL-TG (mg/dL)	7.0 (5.5, 21.0)	22.5 (12.5, 28.7)	0.011
Dense VLDL-apoB (mg/dL)	0.56 (0.21, 1.02)	1.22 (0.79, 2.02)	0.010
Dense VLDL-apoCIII (mg/dL)	0.32 (0.18, 0.69)	0.91 (0.75, 1.43)	0.014
Dense VLDL-apoE (mg/dL)	0.26 (0.06, 0.42)	0.31 (0.12, 0.51)	0.407
IDL-TG (mg/dL)	7.9 (4.5, 11.9)	7.8 (6.2, 14.0)	0.553
IDL-apoB (mg/dL)	2.37 (1.51, 3.91)	4.14 (1.29, 5.05)	0.429
IDL-apoCIII (mg/dL)	0.27 (0.13, 0.41)	0.31 (0.18,0.75)	0.527
IDL-apoE (mg/dL)	0.37 (0.24, 0.49)	0.35 (0.26, 0.59)	0.752
LDL-TG (mg/dL)	11.6 (10.6, 13.7)	11.9 (8.4, 18.1)	0.906
LDL-apoB (mg/dL)	37.6 (29.3, 48.17)	47.8 (39.1, 59.2)	0.123
LDL-apoCIII (mg/dL)	0.86 (0.48,1.70)	0.95 (0.46, 1.24)	0.502
LDL-apoE (mg/dL)	1.14 (0.87, 1.38)	0.93 (0.62, 1.32)	0.323